PARIS, Sept 19 – Britain’s Oxford Glycosciences (LSE: OGS) announced on Tuesday a deal to buy next generation mass spectrometers from Applied Biosystems (NYSE: PEB) as well as an agreement to collaborate with Packard BioScience (Nasdaq: PBSC) to develop protein biochips.

Financial terms of the deals, which represent significant efforts to secure a leading position in the proteomics sector, were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.